Watson signs pact to acquire products related to Teva's proposed acquisition of Barr
Thursday, November 27, 2008 14:00 IST Corona, California
Watson Pharmaceuticals, Inc, a leading specialty pharmaceutical company, announced a definitive agreement to acquire a portfolio of generic pharmaceutical products that are being divested as a result of the proposed merger